SLC50A1 and hepatocellular carcinoma: The upregulation of SLC50A1 promotes HCC proliferation, reduces apoptosis, enhances resistance to DOX and 2-DG, and significantly increases the Warburg effect, thus controlling HCC cell metabolic reprogramming.